Literature DB >> 3597995

Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy.

R O Cannon, W H Schenke, B J Maron, C M Tracy, M B Leon, J E Brush, D R Rosing, S E Epstein.   

Abstract

Fifty patients with hypertrophic cardiomyopathy underwent invasive study of coronary and myocardial hemodynamics in the basal state and during the stress of pacing. The 23 patients with basal obstruction (average left ventricular outflow gradient, 77 +/- 33 mm Hg; left ventricular systolic pressure, 196 +/- 33 mm Hg, mean +/- 1 SD) had significantly lower coronary resistance (0.85 +/- 0.18 versus 1.32 +/- 0.44 mm Hg X min/ml, p less than 0.001) and higher basal coronary flow (106 +/- 20 versus 80 +/- 25 ml/min, p less than 0.001) in the anterior left ventricle, associated with higher regional myocardial oxygen consumption (12.4 +/- 3.6 versus 8.9 +/- 3.3 ml oxygen/min, p less than 0.001) compared with the 27 patients without obstruction (mean left ventricular systolic pressure 134 +/- 18 mm Hg, p less than 0.001). Myocardial oxygen consumption and coronary blood flow were also significantly higher at paced heart rates of 100 and 130 beats/min (the anginal threshold for 41 of the 50 patients) in patients with obstruction compared with those without. In patients with obstruction, transmural coronary flow reserve was exhausted at a heart rate of 130 beats/min; higher heart rates resulted in more severe metabolic evidence of ischemia with all patients experiencing chest pain, associated with an actual increase in coronary resistance. Patients without obstruction also demonstrated evidence of ischemia at heart rates of 130 and 150 beats/min, with 25 of 27 patients experiencing chest pain. In this group, myocardial ischemia occurred at significantly lower coronary flow, higher coronary resistance and lower myocardial oxygen consumption, suggesting more severely impaired flow delivery in this group compared with those with obstruction. Abnormalities in myocardial oxygen extraction and marked elevation in filling pressures during stress were noted in both groups. Thus, obstruction to left ventricular outflow is associated with high left ventricular systolic pressure and oxygen consumption and therefore has important pathogenetic importance to the precipitation of ischemia in patients with hypertrophic cardiomyopathy. Patients without obstruction may have greater impairment in coronary flow delivery during stress.

Entities:  

Mesh:

Year:  1987        PMID: 3597995     DOI: 10.1016/s0735-1097(87)80159-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

Review 1.  Nuclear cardiac imaging in hypertrophic cardiomyopathy.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

Review 2.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 3.  [New developments in parameter-oriented roentgen densitometry perfusion analysis within the scope of heart catheter studies].

Authors:  M Haude; G Caspari; D Baumgart; P Spiller; G Heusch; R Erbel
Journal:  Herz       Date:  1997-04       Impact factor: 1.443

4.  Age-related changes in familial hypertrophic cardiomyopathy phenotype in transgenic mice and humans.

Authors:  Hong-Chang Luo; Iraklis Pozios; Styliani Vakrou; Lars Sorensen; Roselle M Abraham; Theodore Abraham
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

5.  A large conus artery in patients with hypertrophic cardiomyopathy.

Authors:  T Sumimoto; M Hamada; T Ohtani; Y Shigematsu; Y Fujiwara; M Sekiya; K Hiwada
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

6.  Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Tai Sekine; Masao Daimon; Rei Hasegawa; Kiyomi Teramoto; Takayuki Kawata; Nobuhiro Tanaka; Yasuhiro Takei; Kenji Takazawa; Katsuya Yoshida; Issei Komuro
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

7.  Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy.

Authors:  P P Dimitrow; M Krzanowski; W Bodzoń; A Szczeklik; J S Dubiel
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

8.  Impact of alcohol septal ablation on left anterior descending coronary artery blood flow in hypertrophic obstructive cardiomyopathy.

Authors:  Willem G van Dockum; Paul Knaapen; Mark B M Hofman; Joost P A Kuijer; Folkert J ten Cate; Jurrien M ten Berg; Aernout M Beek; Jos W R Twisk; Albert C van Rossum
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-22       Impact factor: 2.357

9.  Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy.

Authors:  Quirino Ciampi; Sandro Betocchi; Maria Angela Losi; Adele Ferro; Alberto Cuocolo; Raffaella Lombardi; Bruno Villari; Massimo Chiariello
Journal:  J Nucl Cardiol       Date:  2007-10-22       Impact factor: 5.952

10.  Progression from hypertrophic cardiomyopathy to dilated cardiomyopathy.

Authors:  L L Cregler
Journal:  J Natl Med Assoc       Date:  1989-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.